Journal Information
Vol. 100. Issue S2.
Mirando hacia el futuro en Dermatología Extraordinario del Centenario. Parte II
Pages 40-48 (December 2009)
Vol. 100. Issue S2.
Mirando hacia el futuro en Dermatología Extraordinario del Centenario. Parte II
Pages 40-48 (December 2009)
Full text access
The Enigmatic Autoimmune Response in Endemic Pemphigus Foliaceus
La enigmática respuesta autoinmunitaria en el pénfigo foliáceo endémico
Visits
4760
G. Flores, Y. Qian, L.A. Díaz
Corresponding author
ldiaz@med.unc.edu

Correspondence: Department of Dermatology. University of North Carolina. Chapel Hill 3100. Thurston Building, CB#7287 Chapel Hill, NC 27599.
Department of Dermatology. University of North Carolina School of Medicine. Chapel Hill. North Carolina. United States of America
This item has received
Article information
Abstract

Endemic pemphigus foliaceus, known as Fogo Selvagem (FS) in Brazil, is a disease characterized by subcorneal blisters and IgG4 anti-dermoglein 1 (Dsg1) autoantibodies. Epidemiological studies of FS strongly an environmental etiology. A 15-year surveillance of the Limao Verde Amerindian reservation in Brazil has uncovered information on the transition of the autoimmune response from the pre-clinical stage to disease state. This incubation time may evolve over several years. The serological markers of the pre-clinical state of FS are IgM anti-Dsg1, IgE and non-IgG4 autoantibodies against Dsg1. The disease stage of FS is characterized by the rise of pathogenic IgG4 anti-Dsg1 autoantibodies. In this review, the authors reviewed the literature on the relevance of the humoral autoimmune response of FS as well as the possible environmental triggers of anti-Dsg1 autoantibody formation. Based on epidemiological observations, the authors hypothesize that the pathogenic IgG4 response in FS may be triggered by hematophagous insect bites.

Key words:
fogo selvagem
desmoglein
pemphigus foliaceus
pemphigus vulgaris
ELISA
Resumen

El pénfigo foliáceo endémico, conocido como fogo selvagem (FS) en Brasil, es una enfermedad caracterizada por ampollas subcórneas y autoanticuerpos IgG4 frente a la desmogleína 1 (Dsg1).

Los estudios epidemiológicos sobre el FS apoyan de manera sólida una etiología ambiental. Un seguimiento durante 15 años de la reserva amerindia de Limao Verde ha revelado información sobre la transición de la respuesta autoinmunitaria desde el estadio preclínico hasta la fase clínica florida. Este periodo de incubación puede desarrollarse a lo largo de varios años. Los marcadores serológicos del estadio preclínico del FS son autoan ticuerpos IgM, IgE y no IgG4 frente a la Dsg1. La fase florida del FS se caracteriza por el aumento de los autoanticuerpos patogénicos IgG4 frente a la Dsg1.

En este artículo los autores revisan la literatura sobre la relevancia de la respuesta humoral autoinmunitaria del FS, así como los posibles factores ambientales desencadenantes para la formación de autoanticuerpos frente a la Dgs-1. Los autores sugieren, basándose en los estudios epidemiológicos, que la respuesta patogénica mediada por IgG4 en el FS puede estar provocada por las picaduras de insectos hematófagos.

Palabras clave:
fogo selvagem
desmogleína
pénfigo foliáceo
pénfigo vulgar
ELISA
Full text is only aviable in PDF
References
[1.]
J.C. Bystryn, J.L. Rudolph.
Pemphigus.
[2.]
M.C. Udey, J.R. Stanley.
Pemphigus-diseases of antidesmosomal autoimmunity.
JAMA, 282 (1999), pp. 572-576
[3.]
G.J. Anhalt, R.S. Labib, J.J. Voorhees, T.F. Beals, L.A. Diaz.
Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease.
N Engl J Med, 306 (1982), pp. 1189-1196
[4.]
J. Roscoe, L. Diaz, S. Sampaio, R. Castro, R. Labib, Y. Takahashi, et al.
Brazilian pemphigus foliaceus autoantibodies are pathogenic to BALB/c mice by passive transfer.
J Invest Dermatol, 85 (1985), pp. 538-541
[5.]
L.A. Diaz, S.A. Sampaio, E.A. Rivitti, C.R. Martins, P.R. Cunha, C. Lombardi, et al.
Endemic pemphigus foliaceus (Fogo Selvagem): II. Current and historic epidemiologic studies.
J Invest Dermatol, 92 (1989), pp. 4-12
[6.]
A.M. Abreu-Velez, T. Hashimoto, W.B. Bollag, S. Tobon Arroyave, C.E. Abreu-Velez, M.L. Londono, et al.
A unique form of endemic pemphigus in northern Colombia.
J Am Acad Dermatol, 49 (2003), pp. 599-608
[7.]
M.A. Robledo, S. Prada, D. Jaramillo, W. León.
South American pemphigus foliaceus: study of an epidemic in El Bagre and Nechi, Colombia 1982 to 1986.
Br J Dermatol, 118 (1988), pp. 737-744
[8.]
J.P. Morini, B. Jomaa, Y. Gorgi, M.H. Saguem, R. Nouira, J.C. Roujeau, et al.
Pemphigus foliaceus in young women. An endemic focus in the Sousse area of Tunisia.
Arch Dermatol, 129 (1993), pp. 69-73
[9.]
L. Diaz, S. Sampaio, E. Rivitti, C. Martins, P. Cunha, C. Lombardi, et al.
Endemic pemphigus foliaceus (fogo selvagem). I. Clinical features and immunopathology.
J Am Acad Dermatol, 20 (1989), pp. 657-669
[10.]
D.J. Emery, L.A. Diaz, J.A. Fairley, A. López, A.F. Taylor, G.J. Giudice.
Pemphigus foliaceus and pemphigus vulgaris autoantibodies react with the extracellular domain of desmoglein-1.
J Invest Dermatol, 104 (1995), pp. 323-328
[11.]
S. Futamura, C. Martins, E.A. Rivitti, R.S. Labib, L.A. Diaz, G.J. Anhalt.
Ultrastructural studies of acantholysis induced in vivo by passive transfer of IgG from endemic pemphigus foliaceus (Fogo Selvagem).
J Invest Dermatol, 93 (1989), pp. 480-485
[12.]
G. Hans-Filho, V. dos Santos, J.H. Katayama, V. Aoki, E.A. Rivitti, S.A. Sampaio, et al.
An active focus of high prevalence of fogo selvagem on an Amerindian reservation in Brazil. Cooperative Group on Fogo Selvagem Research.
J Invest Dermatol, 107 (1996), pp. 68-75
[13.]
Qian Y, Qaqish BF, Andraca E, Flores G, Aoki V, Hans-Filho G, et al. IgE anti-desmoglein 1 autoantibodies and its implication on the etiology of endemic pemphigus foliaceus. 2009 (Submitted).
[14.]
A.K. Abbas, A.H. Lichtman, J.S. Pober.
B cell activation and antibody production. Cellular and molecular immunology. 5th Ed-Updated.
Elsevier Saunders, (2005),
[15.]
R. Hamkar, S. Jalilvand, T. Mokhtari-Azad, K. Nouri Jelyani, H. Dahi-Far, H. Soleimanjahi, et al.
Assessment of IgM enzyme immunoassay and IgG avidity assay for distinguishing between primary and secondary immune response to rubella vaccine.
J Virol Methods, 130 (2005), pp. 59-65
[16.]
N. Obel, M. Hoier-Madsen, H. Kangro.
Serological and clinical findings in patients with serological evidence of reactivated Epstein-Barr virus infection.
APMIS, 104 (1996), pp. 424-428
[17.]
C.M. Chu.
Immunoglobulin class M anti-hepatitis B core antigen for serodiagnosis of acute hepatitis: pitfalls and recommendations.
J Gastroenterol Hepatol, 21 (2006), pp. 789-791
[18.]
Z. Cermakova, O. Ryskova, K. Honegr, E. Cermakova, I. Hanovcova.
Diagnosis of Lyme borreliosis using enzyme immunoanalysis.
Med Sci Monit, 11 (2005), pp. BR121-BR125
[19.]
J.G. Montoya.
Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis.
J Infect Dis, 185 (2002), pp. S73-S82
[20.]
M.M. Reis, M.M. Tessaro, P.A. D’Azevedo.
Toxoplasma-IgM and IgG-avidity in single samples from areas with a high infection rate can determine the risk of mother-to-child transmission.
Rev Inst Med Trop Sao Paulo, 48 (2006), pp. 93-98
[21.]
L.A. Diaz, P.S. Prisayanh, D.A. Dasher, N. Li, F. Evangelista, V. Aoki, et al.
The IgM anti-desmoglein 1 response distinguishes Brazilian pemphigus foliaceus (fogo selvagem) from other forms of pemphigus.
J Invest Dermatol, 128 (2008), pp. 667-675
[22.]
J.J. Manson, C. Mauri, M.R. Ehrenstein.
Natural serum IgM maintains immunological homeostasis and prevents autoimmunity.
Springer Semin Immunopathol, 26 (2005), pp. 425-432
[23.]
A. Coutinho, M.D. Kazatchkine, S. Avrameas.
Natural autoantibodies.
Curr Opin Immunol, 7 (1995), pp. 812-818
[24.]
L. Mouthon, S. Lacroix-Desmazes, A. Nobrega, C. Barreau, A. Coutinho, M.D. Kazatchkine.
The self-reactive antibody repertoire of normal human serum IgM is acquired in early childhood and remains conserved throughout life.
Scand J Immunol, 44 (1996), pp. 243-251
[25.]
R. Ferreira, M. Barreto, E. Santos, C. Pereira, B. Martins, R. Andreia, et al.
Heritable factors shape natural human IgM reactivity to Ro60/SS-A and may predispose for SLE-associated IgG anti-Ro and anti-La autoantibody production.
J Autoimmun, 25 (2005), pp. 155-163
[26.]
F. Forger, T. Matthias, M. Oppermann, H. Becker, K. Helmke.
Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis.
Lupus, 13 (2004), pp. 36-44
[27.]
Q.Z. Li, C. Xie, T. Wu, M. Mackay, C. Aranow, C. Putterman, et al.
Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays.
J Clin Invest, 115 (2005), pp. 3428-3439
[28.]
D. Stahl, M. Hoemberg, U. Cassens, U. Pachmann, W. Sibrowski.
Evidence that human autoimmune thrombocytopenia mediated by both immunoglobulin isotypes IgM and IgG is an independent disease entity.
Eur J Haematol, 75 (2005), pp. 318-327
[29.]
D. Stahl, W. Sibrowski.
Warm autoimmune hemolytic anemia is an IgM-IgG immune complex disease.
J Autoimmun, 25 (2005), pp. 272-282
[30.]
M. Moraes, M. Fernández-Vina, A. Lázaro, L. Diaz Filho, H. Friedman, E. Rivitti, et al.
An epitope in the third hypervariable region of the DRB1 gene is involved in the susceptibility to endemic pemphigus foliaceus (fogo selvagem) in three different Brazilian populations.
Tissue Antigens, 49 (1997), pp. 35-40
[31.]
K. Bhol, K. Natarajan, N. Nagarwalla, A. Mohimen, V. Aoki, A. Ahmed.
Correlation of peptide specificity and IgG subclass with pathogenic and nonpathogenic autoantibodies in pemphigus vulgaris: a model for autoimmunity.
Proc Natl Acad Sci USA, 92 (1995), pp. 5239-5243
[32.]
W. Brooks, Y. Lee, E. Abell, J. Deng.
Comparison of IgG subclasses and complement binding activity of autoantibodies from patients with bullous pemphigoid and pemphigus.
J Clin Lab Anal, 3 (1989), pp. 307-311
[33.]
M. David, V. Katzenelson, B. Hazaz, A. Ben-Chetrit, M. Sandbank.
Determination of IgG subclasses in patients with pemphigus with active disease and in remission.
Arch Dermatol, 125 (1989), pp. 787-790
[34.]
C.C. Jones, R.G. Hamilton, R.E. Jordon.
Subclass distribution of human IgG autoantibodies in pemphigus.
J Clin Immunol, 8 (1988), pp. 43-49
[35.]
T. Parlowsky, J. Welzel, M. Amagai, D. Zillikens, T. Wygold.
Neonatal pemphigus vulgaris: IgG4 autoantibodies to desmoglein 3 induce skin blisters in newborns.
J Am Acad Dermatol, 48 (2003), pp. 623-625
[36.]
M.K. Hacker, M. Janson, J.A. Fairley, M.S. Lin.
Isotypes and antigenic profiles of pemphigus foliaceus and pemphigus vulgaris autoantibodies.
Clin Immunol, 105 (2002), pp. 64-74
[37.]
J.D. Torzecka, K. Wozniak, C. Kowalewski, E. Waszczykowska, A. Sysa-Jedrzejowska, H.H. Pas, et al.
Circulating pemphigus autoantibodies in healthy relatives of pemphigus patients: coincidental phenomenon with a risk of disease development?.
Arch Dermatol Res, 299 (2007), pp. 239-243
[38.]
H. Yamada, T. Hashimoto, T. Nishikawa.
IgG Subclasses of intercellular and basement membrane zone antibodies: the relationship to the capability of complement fixation.
J Invest Dermatol, 92 (1989), pp. 585-587
[39.]
S.W. Yeh, L.A. Cavacini, K.C. Bhol, M.S. Lin, M. Kumar, M. Duval, et al.
Pathogenic human monoclonal antibody against desmoglein 3.
Clin Immunol, 120 (2006), pp. 68-75
[40.]
B. Rock, C.R. Martins, A.N. Theofilopoulos, R.S. Balderas, G.J. Anhalt, R.S. Labib, et al.
The pathogenic effect of IgG4 autoantibodies in endemic pemphigus foliaceus (fogo selvagem).
N Engl J Med, 320 (1989), pp. 1463-1469
[41.]
E.M. Allen, G.J. Giudice, L.A. Diaz.
Subclass reactivity of pemphigus foliaceus autoantibodies with recombinant human desmoglein.
J Invest Dermatol, 100 (1993), pp. 685-691
[42.]
S. Marques Babosa Dos Santos, A. Lima Filgueira, O. Andrade Patrus, L. Diaz.
Perfil evolutivo das subclasses de imunoglobulinas gama em pacientes de pênfigo foliáceo endêmico.
An Bras Dermatol, 76 (2001), pp. 561-574
[43.]
M.K. Hacker-Foegen, M. Janson, M. Amagai, J.A. Fairley, M.S. Lin.
Pathogenicity and epitope characteristics of anti-desmoglein- 1 from pemphigus foliaceus patients expressing only IgG1 autoantibodies.
J Invest Dermatol, 121 (2003), pp. 1373-1378
[44.]
V. Aoki, M.H. Huang, A.M. Perigo, L.M. Fukumori, C.W. Maruta, C.G. Santi, et al.
Endemic pemphigus foliaceus (fogo selvagem) and pemphigus vulgaris: immunoglobulin G heterogeneity detected by indirect immunofluorescence.
Rev Hosp Clin Fac Med Sao Paulo, 59 (2004), pp. 251-256
[45.]
B. Rock, R. Labib, L. Diaz.
Monovalent Fab’immunoglobulin fragments from endemic pemphigus foliaceus autoantibodies reproduce the human disease in neonatal Balb/c mice.
J Clin Invest, 85 (1990), pp. 296-299
[46.]
N. Calvanico, S. Swartz, L. Diaz.
Affinity immunoblotting studies on the restriction of autoantibodies from endemic pemphigus foliaceus patients.
J Autoimmun, 6 (1993), pp. 145-157
[47.]
B.F. Qaqish, P. Prisayanh, Y. Qian, E. Andraca, N. Li, V. Aoki, et al.
Development of an IgG4-based predictor of endemic pemphigus foliaceus (fogo selvagem).
J Invest Dermatol, 129 (2009), pp. 110-118
[48.]
S.J. Warren, M.S. Lin, G.J. Giudice, R.G. Hoffmann, G. Hans-Filho, V. Aoki, et al.
The prevalence of antibodies against desmoglein 1 in endemic pemphigus foliaceus in Brazil. Cooperative Group on Fogo Selvagem Research.
N Engl J Med, 343 (2000), pp. 23-30
[49.]
N. Li, V. Aoki, G. Hans-Filho, E.A. Rivitti, L.A. Diaz.
The role of intramolecular epitope spreading in the pathogenesis of endemic pemphigus foliaceus (fogo selvagem).
J Exp Med, 197 (2003), pp. 1501-1510
[50.]
S. Warren, L. Arteaga, E. Rivitti, V. Aoki, G. Hans-Filho, B. Qaqish, et al.
The role of subclass switching in the pathogenesis of endemic pemphigus foliaceus.
J Invest Dermatol, 120 (2003), pp. 104-108
[51.]
Qian Y, Clarke SH, Aoki V, Hans-Filhio G, Rivitti EA, Diaz LA. Antigen selection of anti-DSG1 autoantibodies during and before the onset of endemic pemphigus foliaceus. J Invest Dermatol. 2009 (In press).
[52.]
G.F. Kalantarov, S.A. Rudchenko, L. Lobel, I. Trakht.
Development of a fusion partner cell line for efficient production of human monoclonal antibodies from peripheral blood lymphocytes.
Hum Antibodies, 11 (2002), pp. 85-96
[53.]
Aranha Campos J. Penfigo foliaceo (Fogo Selvagem). Aspectos clinicos e epidemiologicos. Comp Melhoramentos S Paulo; 1942.
[54.]
A. Auad.
Penfigo foliaceo Sul-Americano no Estado de Goias.
Rev Patol Trop, 1 (1972), pp. 293-346
[55.]
L. Minelli.
Geografia Medica do Penfigo Foliaceo Sul Americano no Estado do Parana.
An Bras Dermatol Sifilol, 51 (1976), pp. 173-181
[56.]
J. Vieira.
Pemphigus Foliaceus (Fogo Selvagem). An endemic disease of the state of Sao Paulo (Brazil).
Arch Dermatol, 41 (1940), pp. 858-863
[57.]
J. Dias, C. Schofield.
The evolution of Chagas disease (American trypanosomiasis) control after 90 years since Carlos Chagas discovery.
Mem Inst Oswaldo Cruz, 94 (1999), pp. 103-121
[58.]
L.V. Kirchhoff.
American trypanosomiasis (Chagas’ disease)–a tropical disease now in the United States.
N Engl J Med, 329 (1993), pp. 639-644
[59.]
S. Williams-Blangero, J.L. VandeBerg, A.R. Teixeira.
Attitudes towards Chagas’ disease in an endemic Brazilian community.
Cad Saude Publica, 15 (1999), pp. 7-13
[60.]
M. Goihman-Yahr.
American mucocutaneous leishmaniasis.
Dermatol Clin, 12 (1994), pp. 703-712
[61.]
S. Klaus, S. Frankenburg.
Cutaneous leishmaniasis in the Middle East.
Clin Dermatol, 17 (1999), pp. 137-141
[62.]
A.C.R. Medeiros, A.M.F. Roselino.
Leishmaniose tegumentar americana: do histórico aos dias de hoje / Cutaneous american leishmaniasis: from the beginning until nowadays.
An Bras Dermatol, 74 (1999), pp. 329-336
[63.]
D.H. Molyneux, C. Morel.
Onchocerciasis and Chagas’ disease control: the evolution of control via applied research through changing development scenarios.
Br Med Bull, 54 (1998), pp. 327-339
[64.]
H.B. Routh, K.R. Bhowmik.
Filariasis.
Dermatol Clin, 12 (1994), pp. 719-727
[65.]
Paes-Leme C. Contribuicao ao estudo do Tokelau. Rio de Janeiro, Brazil: Tese Facultade de Medicina do Rio de Janeiro; 1903.
[66.]
Cunha PR. Sero Epidemiologia do Fogo Selvagem em um Foco Endemico Remanescente do Estado de Sao Paulo. [Tese de Docencia]. Sao Paulo, Brazil: Facultade de Medicina da Universidade de Sao Paulo; 1987.
[67.]
Da Silva LJ. A Agricultura Paulista a Partir de 1950. In: Anexo 3: A Evolucion da Doenca de Chagas no Estado de Sao Paulo. Sao Paulo: Funcraf-Hucite C Publisher; 1999.
[68.]
J. Empinotti, L. Diaz, C. Martins, E. Rivitti, S. Sampaio, C. Lombardi, et al.
Endemic pemphigus foliaceus in western Parana, Brazil (1976-1988). Cooperative Group for Fogo Selvagem Research.
Br J Dermatol, 123 (1990), pp. 431-437
[69.]
J.C. Empinotti, V. Aoki, A. Filgueira, S.A. Sampaio, E.A. Rivitti, J.A. Sanches Jr., et al.
Clinical and serological follow-up studies of endemic pemphigus foliaceus (fogo selvagem) in Western Parana, Brazil (2001-2002).
Br J Dermatol, 155 (2006), pp. 446-450
[70.]
N.G. Proenca.
Declinio do Penfigo Foliaceo no Estado de Sao Paulo.
Rev Paulista Med (Brasil), 89 (1977), pp. 97-100
[71.]
A. Silveira, M. Vinhaes.
Elimination of vector-borne transmission of Chagas disease.
Mem Inst Oswaldo Cruz, 94 (1999), pp. 405-411
[72.]
M.C. Vinhaes, J.C. Dias.
Chagas disease in Brazil.
Cad Saude Publica, 16 (2000), pp. 7-12
[73.]
D.P. Eaton, L.A. Diaz, G. Hans-Filho, V.D. Santos, V. Aoki, H. Friedman, et al.
Comparison of black fly species (Diptera: Simuliidae) on an Amerindian reservation with a high prevalence of fogo selvagem to neighboring disease-free sites in the State of Mato Grosso do Sul, Brazil. The Cooperative Group on Fogo Selvagem Research.
J Med Entomol, 35 (1998), pp. 120-131
[74.]
V. Aoki, R.C. Millikan, E.A. Rivitti, G. Hans-Filho, D.P. Eaton, S.J. Warren, et al.
Environmental risk factors in endemic pemphigus foliaceus (fogo selvagem).
J Investig Dermatol Symp Proc, 9 (2004), pp. 34-40
[75.]
J. Hilario-Vargas, D.A. Dasher, N. Li, V. Aoki, G. Hans-Filho, V. dos Santos, et al.
Prevalence of anti-desmoglein-3 antibodies in endemic regions of Fogo selvagem in Brazil.
J Invest Dermatol, 126 (2006), pp. 2044-2048
[76.]
J.M. Ribeiro.
Blood-feeding arthropods: live syringes or invertebrate pharmacologists?.
Infect Agents Dis, 4 (1995), pp. 143-152
[77.]
P.F. Billingsley, J. Baird, J.A. Mitchell, C. Drakeley.
Immune interactions between mosquitoes and their hosts.
Parasite Immunol, 28 (2006), pp. 143-153
[78.]
D.E. Champagne, H.A. Wasserman, S. Kumar, S. Singh.
Pharmacological and immunological properties of saliva of the blood-feeding insects Rhodnius prolixus and Aedes aegypti.
Physiological Entomology, 29 (2004), pp. 269-277
[79.]
R.D. Gillespie, M.L. Mbow, R.G. Titus.
The immunomodulatory factors of bloodfeeding arthropod saliva.
Parasite Immunol, 22 (2000), pp. 319-331
[80.]
C.M. Theodos, J.M. Ribeiro, R.G. Titus.
Analysis of enhancing effect of sand fly saliva on Leishmania infection in mice.
Infect Immun, 59 (1991), pp. 1592-1598
[81.]
E.C. Manso, F.F. Morato-Castro, C.J. Yee, M. Croce, M.S. Palma, J. Croce.
Honeybee venom specific IgG subclass antibodies in Brazilian beekeepers and in patients allergic to bee stings.
J Investig Allergol Clin Immunol, 8 (1998), pp. 46-51
[82.]
J.G. Valenzuela, Y. Belkaid, M.K. Garfield, S. Mendez, S. Kamhawi, E.D. Rowton, et al.
Toward a defined anti-Leishmania vaccine targeting vector antigens: characterization of a protective salivary protein.
J Exp Med, 194 (2001), pp. 331-342
[83.]
A. Kurniawan, M. Yazdanbakhsh, R. van Ree, R. Aalberse, M.E. Selkirk, F. Partono, et al.
Differential expression of IgE and IgG4 specific antibody responses in asymptomatic and chronic human filariasis.
J Immunol, 150 (1993), pp. 3941-3950
[84.]
A. Roselino, J. Figueredo, K. Kounga, V. Reddy, E. Lerner.
Serum IgG from pemphigus foliaceus patients reacts against maxadilan.
J Invest Dermatol, 117 (2001), pp. 460
[85.]
B. Arca, F. Lombardo, J.G. Valenzuela, I.M. Francischetti, O. Marinotti, M. Coluzzi, et al.
An updated catalogue of salivary gland transcripts in the adult female mosquito, Anopheles gambiae.
J Exp Biol, 208 (2005), pp. 3971-3986
[86.]
D.E. Champagne, R.H. Nussenzveig, J.M. Ribeiro.
Purification, partial characterization, and cloning of nitric oxide-carrying heme proteins (nitrophorins) from salivary glands of the blood-sucking insect Rhodnius prolixus.
J Biol Chem, 270 (1995), pp. 8691-8695
[87.]
R. Charlab, J.G. Valenzuela, E.D. Rowton, J.M. Ribeiro.
Toward an understanding of the biochemical and pharmacological complexity of the saliva of a hematophagous sand fly Lutzomyia longipalpis.
Proc Natl Acad Sci U S A, 96 (1999), pp. 15155-15160
[88.]
J.G. Valenzuela, Y. Belkaid, E. Rowton, J.M. Ribeiro.
The salivary apyrase of the blood-sucking sand fly Phlebotomus papatasi belongs to the novel Cimex family of apyrases.
J Exp Biol, 204 (2001), pp. 229-237
[89.]
J.G. Valenzuela, M. Garfield, E.D. Rowton, V.M. Pham.
Identification of the most abundant secreted proteins from the salivary glands of the sand fly Lutzomyia longipalpis, vector of Leishmania chagasi.
J Exp Biol, 207 (2004), pp. 3717-3729
[90.]
W. Hemmer, M. Focke, D. Kolarich, I. Dalik, M. Gotz, R. Jarisch.
Identification by immunoblot of venom glycoproteins displaying immunoglobulin E-binding N-glycans as cross-reactive allergens in honeybee and yellow jacket venom.
Clin Exp Allergy, 34 (2004), pp. 460-469
[91.]
P. Volf, P. Tesarova, E.N. Nohynkova.
Salivary proteins and glycoproteins in phlebotomine sandflies of various species, sex and age.
Med Vet Entomol, 14 (2000), pp. 251-256
[92.]
E. Hill, I.D. Broadbent, C. Chothia, J. Pettitt.
Cadherin superfamily proteins in Caenorhabditis elegans and Drosophila melanogaster.
J Mol Biol, 305 (2001), pp. 1011-1024
[93.]
D.J. Barrett, E.M. Ayoub.
IgG2 subclass restriction of antibody to pneumococcal polysaccharides.
Clin Exp Immunol, 63 (1986), pp. 127-134
[94.]
Q. Vos, A. Lees, Z.Q. Wu, C.M. Snapper, J.J. Mond.
B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms.
Immunol Rev, 176 (2000), pp. 154-170
[95.]
B.A. Cobb, D.L. Kasper.
Coming of age: carbohydrates and immunity.
Eur J Immunol, 35 (2005), pp. 352-356
[96.]
J. Nedelec, J. Boucraut, J.M. Garnier, D. Bernard, G. Rougon.
Evidence for autoimmune antibodies directed against embryonic neural cell adhesion molecules (N-CAM) in patients with group B meningitis.
J Neuroimmunol, 29 (1990), pp. 49-56
Copyright © 2009. Academia Española de Dermatología y Venereología
Download PDF
Idiomas
Actas Dermo-Sifiliográficas
Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?